Skip to main content
Takeda Pharmaceutical Company Limited logo

Takeda Pharmaceutical Company Limited — Investor Relations & Filings

Ticker · 4502 ISIN · JP3463000004 LEI · 549300ZLMVP4X0OGR454 T Manufacturing
Filings indexed 92 across all filing types
Latest filing 2026-05-19 Legal Proceedings Report
Country JP Japan
Listing T 4502

About Takeda Pharmaceutical Company Limited

https://www.takeda.com/

Takeda Pharmaceutical Company Limited is a global, patient-focused, and R&D-driven biopharmaceutical company dedicated to discovering and delivering life-transforming treatments. The company's mission is to provide better health for people and a brighter future for the world. Its core therapeutic areas of focus include oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests significantly in Plasma-Derived Therapies and Vaccines. The company's operations encompass the entire pharmaceutical value chain, from translating science into highly innovative medicines through research and development to manufacturing, sales, and marketing on a global scale.

Recent filings

Filing Released Lang Actions
Takeda Pharmaceutical Company Limited: Takeda Provides an Update regarding Jury Verdict in AMITIZA (lubiprostone) Antitrust Litigation in the U.S. and Related Revision to FY2025 Financial Results
Legal Proceedings Report Classification · 85% confidence The document is an ad-hoc press release disclosing inside information under EU MAR. It provides an update on a U.S. jury verdict in an AMITIZA antitrust litigation and discusses Takeda’s planned revision of FY2025 financial results as a consequence. There are no full financial statements or earnings data as would be found in an Annual or Interim Report, nor is it a notice of dividend, capital change, or a shareholder meeting. Instead, it is a legal proceedings update regarding significant litigation. Therefore, it fits the “Legal Proceedings Report” category (Code: LTR).
2026-05-19 English
訂正発行登録書
Share Issue/Capital Change Classification · 80% confidence The document is a Japanese "訂正発行登録書" (corrected issuance registration statement) filed under the Financial Instruments and Exchange Act. It details the registration of a share issuance (types of securities, amounts, effective dates, etc.). This is not merely a report announcement but the actual regulatory filing to register new shares. According to our taxonomy, announcements or filings regarding new share issues or capital changes fall under Share Issue/Capital Change (SHA).
2026-05-19 Japanese
訂正発行登録書
Capital/Financing Update Classification · 75% confidence The document is a correction (“訂正”) to an issuance registration statement under the Financial Instruments and Exchange Act – i.e., an amendment to the corporate bond registration used to raise capital. It is not an annual or interim report, nor a simple notice of report publication, but a filing related to a financing activity (bond issuance). This falls squarely under “Capital/Financing Update.”
2026-05-19 Japanese
臨時報告書
Legal Proceedings Report Classification · 90% confidence The document is a Japanese 臨時報告書 (Timely Report) filed under the Financial Instruments and Exchange Act to disclose a material antitrust lawsuit verdict and potential damages. It provides an update on a significant legal proceeding affecting the company’s financial position. This aligns directly with “Legal Proceedings Report (LTR)” in our taxonomy.
2026-05-19 Japanese
AMITIZA(ルビプロストン)に係る米国の反トラスト訴訟における陪審評決および関連する2026年3月期(2025年度)決算値の修正について
Legal Proceedings Report Classification · 89% confidence The document is a corporate news release detailing a significant U.S. antitrust lawsuit verdict against Takeda and outlining related adjustments to the company’s March 2026 year-end financial results. It focuses primarily on legal proceedings, court decisions, potential appeals, and the impact on accounting provisions. This matches the definition of Legal Proceedings Report (LTR).
2026-05-19 Japanese
6-K - TAKEDA PHARMACEUTICAL CO LTD (0001395064) (Filer)
Regulatory Filings
2026-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.